Surface Logix, Inc. is developing a product pipeline using its Pharmacomer™ Technology Platform to create New Chemical Entities (NCEs) that target specific tissues and organ systems. The company is advancing multiple internal programs in the areas of metabolic, cardiovascular and other diseases.

To learn more about a particular indication, please select the corresponding program from the pipeline:

  
   

 

 
 
 
Home | About Us | Pipeline | Platform | Partnering | News & Events | Contact Us | Careers | Site Map
Surface Logix, Inc.  All Rights Reserved Copyright
 
<script language="javascr